[S-27] Current topics in Guillain-Barré syndrome - from pathophysiology to clinical features

[S-27-2] Ca2+-dependent anti-GQ1b antibody: From a new assay method to an insight for paranodal gangliosides

Atsuro Chiba (Department of Neurology, Faculty of Medicine, Kyorin University, Japan)

This symposium is designed to introduce novel international studies of clinical and basic research from leading laboratories as well as to discuss current topics in the field of Guillain-Barré syndrome (GBS). The International GBS Outcome Study (IGOS) which has been just accomplished is a worldwide prospective, collaborative study of GBS, results of which will be global standards and provide evidence about a new clinical guideline of GBS. In addition, recently-reported new observations of antibody-mediated pathophysiology in GBS are expected to improve diagnostic approach, change the concept of electrophysiological categories, and develop promising immunotherapies and treatment strategy. This symposium will stimulate neurologists to absorb such novel knowledge and to put it to a practical use without regard to their specialty.

Education/Degrees:
1985 M.D. Tokyo University, Tokyo, Japan, General Medicine
1994 Ph.D. Tokyo University, Tokyo, Japan, Neurology

Positions:
1985 Resident, Tokyo University Hospital, and Showa General Hospital
1990 Clinical staff, Departments of Neurology, Tokyo University Hospital
1993 Post-doctoral fellow, Department of Biochemistry, Institute of Medical Science, University of Tokyo, and Section for Glycobiology, Tokyo Metropolitan Institute of Gerontology
1995 Clinical staff. Departments of Neurology, Tokyo University Hospital
1996 Research fellow, Department of Pharmacology, New York Medical Center
2000 Lecturer, Departments of Neurology, Kyorin University
2002 Associate Professor, Departments of Neurology, Kyorin University
2007 Professor, Departments of Neurology, Kyorin University